Cargando…
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Parkinson disease (PD) is a severe neurodegenerative disorder that affects around 2% of the population over 65 years old. It is characterized by the progressive loss of nigrostriatal dopaminergic neurons, resulting in motor disabilities of the patients. At present, only symptomatic cures are availab...
Autores principales: | Agostini, Francesco, Masato, Anna, Bubacco, Luigi, Bisaglia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745385/ https://www.ncbi.nlm.nih.gov/pubmed/35008822 http://dx.doi.org/10.3390/ijms23010398 |
Ejemplares similares
-
α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease
por: Agostini, Francesco, et al.
Publicado: (2023) -
Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020) -
Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012) -
Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
por: Filograna, Roberta, et al.
Publicado: (2016) -
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)